Subscription to press releases

The Share
Press Releases
Financial reports
Financial calendar
Financial presentations
Corporate governance

Experts in inhalation medicine

Iconovo develops inhalation medicines in strategic partnership with other pharmaceutical companies. Combining our diverse portfolio of patented dry powder inhalers with considerable drug formulation expertise, we have the capacity for end-to-end product development in this area.

Iconovo AB

Visiting address
Ideon, Delta 6 LUND
Ideongatan 3B

Postal address
Iconovo AB
Ideongatan 3A-B
SE-223 62 LUND
Sweden

Press releases

Subscription